Progesterone withdrawal signals labor in mammals. Elevated intracellular metabolism contributes to progesterone functional withdrawal through unknown mechanism, which is thought to act via progesterone receptor (PR). This study aims to investigate molecular mechanisms underlying progesterone withdrawal during pregnancy and labor. We investigated the role of 5α-reductase type I (SRD5A1) in enzymatic catalysis of progesterone and loss of PR function in a human trophoblast choriocarcinoma cell line JEG3. The PR isoform B (PR-B) was robustly expressed in JEG3 cells. The SRD5A1 small-interfering RNA knockdown led to significant increase in PR-B nuclear import, ectopic, whereas SRD5A1 overexpression resulted in remarkable inhibition of nuclear PR-B in P4-treated cells. Repression of SRD5A1 activated PR-B responsive gene, whereas overexpression of SRD5A1 possessed an inhibitory effect. JEG3 cell line is a valuable tool to study mechanisms responsible for loss of PR function and screening of drugs for preterm birth treatment. Our study aims to investigate the molecular mechanisms underlying progesterone withdrawal during pregnancy and labor.
PetragliaFImperatoreAChallisJR. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev. 2010;31(6):783–816.
2.
PetragliaFSawchenkoPERivierJValeW. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature. 1987;328(6132):717–719.
3.
SpazianiEPO’BrienWFBenoitRRGouldSF. Corticotropin-releasing hormone increases the expression of the prostaglandin E(2) receptor subtype EP1 in amnion WISH cells. Biol Reprod. 2000;62(1):23–26.
4.
MendelsonCR. Minireview: fetal–maternal hormonal signaling in pregnancy and labor. Mol Endocrinol. 2009;23(7):947–954.
5.
KaralisKGoodwinGMajzoubJA. Cortisol blockade of progesterone: a possible molecular mechanism involved in the initiation of human labor. Nat Med. 1996;2(5):556–560.
6.
WetendorfMDeMayoFJ. Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus. Int J Dev Biol. 2014;58(2-4):95–106.
7.
ChaJSunXDeySK. Mechanisms of implantation: strategies for successful pregnancy. Nat Med. 2012;18(12):1754–1767.
8.
SfakianakiAKNorwitzER. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med. 2006;19(12):763–772.
9.
MahendrooMSCalaKMLandrumDPRussellDW. Fetal death in mice lacking 5alpha-reductase type 1 caused by estrogen excess. Mol Endocrinol. 1997;11(7):917–927.
10.
MahendrooMSPorterARussellDWWordRA. The parturition defect in steroid 5alpha-reductase type 1 knockout mice is due to impaired cervical ripening. Mol Endocrinol. 1999;13(6):981–992.
11.
BurleighDWKendziorskiCMChoiYJ. Microarray analysis of BeWo and JEG3 trophoblast cell lines: identification of differentially expressed transcripts. Placenta. 2007;28(5-6):383–389.
12.
LeeRHStanczykFZStolzAJiQYangGGoodwinTM. AKR1C1 and SRD5A1 messenger RNA expression at term in the human myometrium and chorioamniotic membranes. Am J Perinatol. 2008;25(9):577–582.
13.
BainDLHeneghanAFConnaghan-JonesKDMiuraMT. Nuclear receptor structure: implications for function. Annu Rev Physiol. 2007;69:201–220.
14.
Guiochon-MantelALescopPChristin-MaitreSLoosfeltHPerrot-ApplanatMMilgromE. Nucleocytoplasmic shuttling of the progesterone receptor. EMBO J. 1991;10(12):3851–3859.
15.
ZachariadesEFosterHGoumenouAThomasPRand-WeaverMKarterisE. Expression of membrane and nuclear progesterone receptors in two human placental choriocarcinoma cell lines (JEG-3 and BeWo): effects of syncytialization. Int J Mol Med. 2011;27(6):767–774.
16.
BaillyALe PageCRauchMMilgromE. Sequence-specific DNA binding of the progesterone receptor to the uteroglobin gene: effects of hormone, antihormone and receptor phosphorylation. EMBO J. 1986;5(12):3235–3241.
17.
ComptonJGSchraderWTO’MalleyBW. DNA sequence preference of the progesterone receptor. Proc Natl Acad Sci USA. 1983;80(1):16–20.
18.
GarfieldREGascJMBaulieuEE. Effects of the antiprogesterone RU 486 on preterm birth in the rat. Am J Obstet Gynecol. 1987;157(5):1281–1285.
19.
MeisPJKlebanoffMThomE. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med. 2003;348(24):2379–2385.
20.
WangBParobchakNRosenMRocheNRosenT. Negative effects of progesterone receptor isoform-A on human placental activity of the noncanonical NF-kappaB signaling. J Clin Endocrinol Metab. 2014;99:E320–E328.
21.
PiekorzRPGingrasSHoffmeyerAIhleJNWeinsteinY. Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase. Mol Endocrinol. 2005;19(2):431–440.
22.
GoldenbergRLCulhaneJFIamsJDRomeroR. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84.
23.
IshidaMChoiJHHirabayashiK. Reproductive phenotypes in mice with targeted disruption of the 20alpha-hydroxysteroid dehydrogenase gene. J Reprod Dev. 2007;53(3):499–508.
24.
RobinsonBGEmanuelRLFrimDMMajzoubJA. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc Natl Acad Sci USA. 1988;85(14):5244–5248.
25.
McLeanMBisitsADaviesJWoodsRLowryPSmithR. A placental clock controlling the length of human pregnancy. Nat Med. 1995;1(5):460–463.
26.
MesianoSChanECFitterJTKwekKYeoGSmithR. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab. 2002;87(6):2924–2930.
27.
PieberDAllportVCHillsFJohnsonMBennettPR. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod. 2001;7(9):875–879.
28.
CondonJCJeyasuriaPFaustJMWilsonJWMendelsonCR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci USA. 2003;100(16):9518–9523.
29.
DongXShylnovaOChallisJRLyeSJ. Identification and characterization of the protein-associated splicing factor as a negative co-regulator of the progesterone receptor. J Biol Chem. 2005;280(14):13329–13340.
30.
BlackCBDuensingTDTrinkleLSDunlayRT. Cell-based screening using high-throughput flow cytometry. Assay Drug Dev Technol. 2011;9(1):13–20.
